There is an error in Table 1. The value listed under GDF-15, Mean (pg/ul), Group 2, should be 2043, not 20443. Please see the correct Table 1 and its caption below.
Table 1. Serum concentration of GDF-15 and FGF-21 in patients and controls.
GDF-15 | |||
Group | Mean (pg/ul) | SEM | Range (pg/ul) |
1 | 7593 | 3870 | 205–85252 |
2 | 2043 | 482.7 | 286–6926 |
3 | 1813 | 788.8 | 149–13370 |
4 | 349.1 | 32.21 | 147–809 |
5 | 350.3 | 20.69 | 155–584 |
FGF-21 | |||
1 | 966.5 | 231 | 25–3623 |
2 | 1106 | 345.7 | 6–5879 |
3 | 522.1 | 195 | 17–2658 |
4 | 136.1 | 43.87 | 30–837 |
5 | 77.59 | 10.3 | 21–285 |
SEM: Standard error of the mean. Group 1: patients with molecularly confirmed mitochondrial disease, Group 2: patients with definitive mitochondrial disease, Group 3: patients with probable mitochondrial disease. Group 4: patients with non-mitochondrial myopathy. Group 5: healthy controls.
Fig 4 appears incorrectly in the published article. Please see the correct Fig 4 and its caption below.
Fig 4. Histogram representing the percentage of patients in each group with both GDF-15 and FGF-21above cut-off values, GDF-15 or FGF-21 elevated or both factors within normal values.
The publisher apologizes for the errors.
Reference
- 1.Montero R, Yubero D, Villarroya J, Henares D, Jou C, Rodríguez MA, et al. (2016) GDF-15 Is Elevated in Children with Mitochondrial Diseases and Is Induced by Mitochondrial Dysfunction. PLoS ONE 11(2): e0148709 doi:10.1371/journal.pone.0148709 [DOI] [PMC free article] [PubMed] [Google Scholar]